Stocks and Investing Stocks and Investing
Thu, March 20, 2014
Wed, March 19, 2014
Tue, March 18, 2014
Mon, March 17, 2014
Fri, March 14, 2014
Wed, March 12, 2014
Tue, March 11, 2014
Mon, March 10, 2014

Andrew Fein Initiated (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014


Published on 2024-10-25 04:25:27 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $21 on, Mar 10th, 2014.

Andrew has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Kim of "Oppenheimer" Initiated at Hold on, Thursday, February 27th, 2014


This is the rating of the analyst that currently disagrees with Andrew


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Tuesday, January 28th, 2014
Contributing Sources